|
Quotes & Info
|
| ISCO > SEC Filings for ISCO > Form 8-K on 5-Dec-2012 | All Recent SEC Filings |
5-Dec-2012
Change in Directors or Principal Officers
Effective November 30, 2012, Mr. Jeffrey Janus resigned from his position as the Senior Vice President of International Stem Cell Corporation, a Delaware corporation (the "Company").
As previously disclosed, on March 9, 2012 Mr. Janus and the Company had entered into a consulting services agreement for a term of five years (the "Agreement") to allow the Company to continue to access Mr. Janus' historical knowledge and experience. Beginning on December 17, 2012, it is expected that Mr. Janus will provide consulting services to the Company pursuant to the terms of the Agreement.
Dated: December 4, 2012
|
|